After racking up $134.3 million in losses over the past seven years, Tempe, AZ-based Capstone Therapeutics ($CAPS) is delaying the release of data from a mid-stage study of its lead drug and struggling to avoid being delisted as its shares trade...
The number one rule of value investing (as coined by Warren Buffett) is: Don't lose money. Hence the appeal of net-nets (stocks trading below their net current asset values), since they offer a dollar of tangible, liquid assets at a discount. But...
Oops! Unable to complete your request. Please refresh your browser.
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.